Publications

Journals

• Papagatsias T; Athanasopoulos T; Meiser A; Benlahrech A; Li F; Self S; Harris J; Roesen N; et alBachy V; Klavinskis L; Fisher K; Oh S; Kwong S; Daniels R; Seymour L; Dickson G; Patterson S. (1 Jan 2009). Using ubiquitin fusion to augment CD8+T cell immune responses against HIV-1 antigens. RETROVIROLOGY. 6. Author weblink.
• Benlahrech A; Harris J; Meiser A; Papagatsias T; Hornig J; Hayes P; Lieber A; Athanasopoulos T; et alBachy V; Daniels R; Fisher K; Gotch F; Klavinskis L; Seymour L; Logan K; Barbagallo R; Dickson G; Patterson S. (1 Jan 2009). Adenovirus vectors induce expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 infection. RETROVIROLOGY. 6. Author weblink.
• Benlahrech A; Harris J; Meiser A; Papagatsias T; Hornig J; Hayes P; Lieber A; Athanasopoulos T; et alBachy V; Csomor E; Daniels R; Fisher K; Gotch F; Seymour L; Logan K; Barbagallo R; Klavinskis L; Dickson G; Patterson S. (24 Nov 2009). Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. Proc Natl Acad Sci U S A. 106:19940-19945. DOI.
• Meiser A; Mueller A; Wise EL; McDonagh EM; Petit SJ; Saran N; Clark PC; Williams TJ; et alPease JE. (15 May 2008). The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor. JOURNAL OF IMMUNOLOGY. 180:6713-6724. Author weblink.
• Mueller A; Meiser A; McDonagh EM; Fox JM; Petit SJ; Xanthou G; Williams TJ; Pease JE. (Apr 2008). CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3. J Leukoc Biol. 83:875-882. DOI.

Conferences

• Athanasopoulos T; Papagatsias T; Meiser A; Harris J; Bachy V; Benlahrech A; Herath S; Kwon S-Y; et alFischer K; Seymour L; Daniels R; Almond N; Logan K; Klavinskis L; Patterson S; Dickson G. Fragmentation, ubiquitination and mosaicism of HIV/SIV genetic components in the context of thermo-stable adenoviral (Ad) vectors as novel vaccine approaches against HIV-1/AIDS. 35th Congress of the Federation-of-European-Biochemical-Societies, 26 Jun 2010 - 1 Jul 2010. 277:109-109. WILEY-BLACKWELL PUBLISHING, INC (1 Jun 2010). Author weblink.
• Athanasopoulos T; Papagatsias T; Meiser A; Harris J; Bachy V; Benlahrech A; Herath S; Roesen N; et alOh S; Li F; Self S; Kwon S-Y; Fischer K; Seymour L; Daniels R; Almond N; Klavinskis L; Logan K; Patterson S; Dickson G. Development and Assessment of Thermo-Stable Adenovirus (Ad)-Based Vaccines Expressing Ubiquitinated and Genetically Fragmented HIV/SIV Genetic Components. 7th Annual Conference of the British-Society-for-Gene-Therapy, 29 Mar 2010 - 31 Mar 2010. 21:520-520. MARY ANN LIEBERT INC (1 Apr 2010). Author weblink.
• Athanasopoulos T; Papagatsias T; Meiser A; Harris J; Bachy V; Benlahrech A; Herath S; Roesen N; et alOh S; Li F; Self S; Kwon S-Y; Fischer K; Seymour L; Daniels R; Almond N; Klavinskis L; Logan K; Patterson S; Dickson G. Development of thermo-stable Ad-based vaccines expressing ubiquitin fusions of full or fragmented HIV/SIV genetic components. Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, 21 Nov 2009 - 25 Nov 2009. 20:1392-1393. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
• Papagatsias T; Athanasopoulos T; Bouzeboudjen Z; Harris J; Benlahrech A; Meiser A; Barbagallo R; Dickson G; et alPatterson S. Using Ubiquitin Fusion to Augment Immune Responses against HIV-1 Antigens. AIDS Vaccine 2008 Conference, 13 Oct 2008 - 16 Oct 2008. 24:141-141. MARY ANN LIEBERT INC (1 Oct 2008). Author weblink.
• Athanasopoulos T; Papagatsias T; Harris J; Bachy V; Benlahrech A; Csomor E; Meiser A; Roesen N; et alOh S-J; Li F; Donnell D; Self S; Kwon S-Y; Fisher K; Seymour L; Daniels R; Klavinskis L; Barbagallo R; Patterson S; Dickson G. Ubiquitination and segmentation of HIV genetic components: Aiming towards an HIV vaccine inducing broad(er) T cell immune responses. 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, 13 Nov 2008 - 16 Nov 2008. 19:1143-1143. MARY ANN LIEBERT INC (1 Oct 2008). Author weblink.
• Harris J; Athanasopoulos T; Bachy V; Papagatsias T; Benlahrech A; Csomor E; Meiser A; Roesen N; et alOh S-J; Seymour L; Fisher K; Daniels R; Barbagallo R; Patterson S; Klavinskis L; Dickson G. Assessment of adenoviral vectors in gel formulations in vitro and in vivo: Aiming towards development of an HIV-1 vaccine. 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, 13 Nov 2008 - 16 Nov 2008. 19:1142-1142. MARY ANN LIEBERT INC (1 Oct 2008).